Lansberg Maarten G, Thijs Vincent N, Bammer Roland, Kemp Stephanie, Wijman Christine A C, Marks Michael P, Albers Gregory W
Stanford University, Stanford Stroke Center, Palo Alto, California 94304, USA.
Stroke. 2007 Aug;38(8):2275-8. doi: 10.1161/STROKEAHA.106.480475. Epub 2007 Jun 14.
Studies evaluating predictors of tPA-associated symptomatic intracerebral hemorrhage (SICH) have typically focused on clinical and CT-based variables. MRI-based variables have generally not been included in predictive models, and little is known about the influence of reperfusion on SICH risk.
Seventy-four patients were prospectively enrolled in an open-label study of intravenous tPA administered between 3 and 6 hours after symptom onset. An MRI was obtained before and 3 to 6 hours after tPA administration. The association between several clinical and MRI-based variables and tPA-associated SICH was determined using multivariate logistic regression analysis. SICH was defined as a > or = 2 point change in National Institutes of Health Stroke Scale Score (NIHSSS) associated with any degree of hemorrhage on CT or MRI. Reperfusion was defined as a decrease in PWI lesion volume of at least 30% between baseline and the early follow-up MRI.
SICH occurred in 7 of 74 (9.5%) patients. In univariate analysis, NIHSSS, DWI lesion volume, PWI lesion volume, and reperfusion status were associated with an increased risk of SICH (P<0.05). In multivariate analysis, DWI lesion volume was the single independent baseline predictor of SICH (odds ratio 1.42; 95% CI 1.13 to 1.78 per 10 mL increase in DWI lesion volume). When early reperfusion status was included in the predictive model, the interaction between DWI lesion volume and reperfusion status was the only independent predictor of SICH (odds ratio 1.77; 95% CI 1.25 to 2.50 per 10 mL increase in DWI lesion volume).
Patients with large baseline DWI lesion volumes who achieve early reperfusion appear to be at greatest risk of SICH after tPA therapy.
评估组织型纤溶酶原激活剂(tPA)相关症状性脑出血(SICH)预测因素的研究通常聚焦于临床和基于CT的变量。基于MRI的变量一般未纳入预测模型,且关于再灌注对SICH风险的影响知之甚少。
74例患者前瞻性纳入一项开放标签研究,在症状发作后3至6小时静脉给予tPA。在tPA给药前及给药后3至6小时进行MRI检查。使用多因素逻辑回归分析确定几个临床和基于MRI的变量与tPA相关SICH之间的关联。SICH定义为美国国立卫生研究院卒中量表评分(NIHSSS)较基线升高≥2分,且CT或MRI显示有任何程度的出血。再灌注定义为基线与早期随访MRI之间灌注加权成像(PWI)病变体积减少至少30%。
74例患者中有7例(9.5%)发生SICH。单因素分析中,NIHSSS、弥散加权成像(DWI)病变体积、PWI病变体积和再灌注状态与SICH风险增加相关(P<0.05)。多因素分析中,DWI病变体积是SICH唯一的独立基线预测因素(优势比1.42;DWI病变体积每增加10 mL,95%可信区间为1.13至1.78)。当早期再灌注状态纳入预测模型时,DWI病变体积与再灌注状态之间的交互作用是SICH唯一的独立预测因素(优势比1.77;DWI病变体积每增加10 mL,95%可信区间为1.25至2.50)。
基线DWI病变体积大且实现早期再灌注的患者在tPA治疗后发生SICH的风险似乎最高。